Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Comment by tylerreddickon Apr 05, 2024 12:46pm
93 Views
Post# 35973157

RE:RE:What a fail....

RE:RE:What a fail....
forhandlaren wrote: Simply put - Howard choose to stay as CEO instead of handing over to whoever and thereby close the private placement as planned.

The only way to justify this is by an impressive NR round the corner that provide cash.


That is nonsense. SBM can't afford a new CEO, who would demand a bigger paycheck, and likely wouldn't invest any of his own money in the stock, just take freebies.

So say what you want, Howie is the only CEO we can afford right now, and he has been investing some of his own cash in the company. Yes, I would have liked to see him participate in this financing, but he was already in the process of lending SBM a million bucks, so no one should be surprised he didn't buy into the PP. I am not.

Yes, it will be a tough slog going forward if the AbbVie jerks keep doing nothing, and we will need more operating cash. But the finish line is in sight, so anyone who has been here for any length of time may as well hold on a little longer.
<< Previous
Bullboard Posts
Next >>